Seventeen-year-old Cassie Hobbes has a gift for profiling people. Her talent has landed her a spot in an elite FBI program for teens with innate crime-solving abilities, and into some harrowing situations. After barely escaping a confrontation with an unbalanced killer obsessed with her mother s murder, Cassie hopes she and the rest of the team can stick to solving cold cases from a distance.
Cassie Hobbes and the other members of the Naturals program of the FBI work to solve a string of serial murders carried out by a copycat killer. The plot contains sexual situations and graphic violence. Book #2
Seventeen-year-old Cassie Hobbes has a gift for profiling people. Her talent has landed her a spot in an elite FBI program for teens with innate crime-solving abilities, and into some harrowing situations. After barely escaping a confrontation with an unbalanced killer obsessed with her mother s murder, Cassie hopes she and the rest of the team can stick to solving cold cases from a distance.
Cassie Hobbes and the other members of the Naturals program of the FBI work to solve a string of serial murders carried out by a copycat killer. The plot contains sexual situations and graphic violence. Book #2
Three casinos. Three bodies. Three days. After a string of brutal murders in Las Vegas, Cassie Hobbes and the Naturals are called in to investigate. But even with the team's unique profiling talents, these murders seem baffling: unlike many serial killers, this one uses different methods every time. All of the victims were killed in public, yet the killer does not show up on any security feed. And each victim has a string of numbers tattooed on their wrist. Hidden in the numbers is a code-and the closer the Naturals come to unraveling the mystery, the more perilous the case becomes.
NATIONAL BESTSELLER • The gripping story of Elizabeth Holmes and Theranos—one of the biggest corporate frauds in history—a tale of ambition and hubris set amid the bold promises of Silicon Valley, rigorously reported by the prize-winning journalist. With a new Afterword. “Chilling ... Reads like a thriller ... Carreyrou tells [the Theranos story] virtually to perfection.” — The New York Times Book Review In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.5 billion. There was just one problem: The technology didn’t work. Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments. All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivings—from journalists to their own employees.
